12th World Cancer Conference
Murugan Avaniyapuram Kannan
King Faisal Specialist Hospital and Research Center, Saudi Arabia
Murugan Avaniyapuram Kannan completed his PhD from the Dept. of Molecular Oncology, Tokyo Medical and Dental University, Tokyo, Japan and postdoctoral studies from Hoshi University, Tokyo, Japan and The Johns Hopkins University School of Medicine, Baltimore, USA. Currently, he is a Scientist in the Dept. of Molecular Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. He has published more than 30 papers in reputed journals and holding a patent for identification of novel ALK mutations in anaplastic thyroid cancer. His research focuses on molecular biology of head and neck squamous cell carcinoma and thyroid cancer identifying molecular therapeutic targets and biomarkers. He has been serving as reviewer in thyroid, PLOS One, Cancer Research, Tumor Biology, Endocrine Related Cancer, Oral Oncology.